Clinical Trial Update: Randomised EValuation of Therapies for microvAscuLar Injury in STEACS [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating therapies to reduce microvascular injury in ST-elevation myocardial infarction. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Snippet

Sponsor: CorFlow Therapeutics AG | Conditions: STEMI (ST Elevation MI) | Phase 2 | Status: NOT_YET_RECRUITING